key: cord-0761850-xgu6vab4 authors: Vavougios, George D. title: Selenium – associated gene signatures within the SARS-CoV-2 – host genomic interaction interface date: 2020-07-15 journal: Free Radic Biol Med DOI: 10.1016/j.freeradbiomed.2020.07.014 sha: 78b3d579578aa398da4844bbc27c30fd0d9dfd7c doc_id: 761850 cord_uid: xgu6vab4 A recent study by Sies and Parnham expanded on the therapeutic potential of Epselen, an organoselenium compound, as an inhibitor of SARS-CoV-2’s main protease. In this study, using an unbiased, data driven bioinformatic screening of two independently extracted SARS-CoV-2 – induced host gene signatures confirms Selenium as a potential drug candidate. This pathway based approach adds transcriptomic evidence complimenting the protein-centered rationale expanded on by the authors. Given that aside from host – protein interactions, antisense transcript mRNA-mRNA interactions have been demonstrated to occur at selenocysteine related insertions in RNA viruses, transcriptomic-level evidence offer unique insight into viral lifecycles. Furthermore, the pathways identified from these two selenium associated signatures provide further insight into the perturbations of selenium metabolism introduced by SARS-CoV-2 during its lifecycle. • Ethics approval and consent to participate : Not applicable. • Consent for publication : Not applicable / Single Author • Availability of data and materials : Not applicable. • Competing interests : None declared. • Funding : No funding source. • Authors' contributions : Single Author. • Acknowledgements: To Mrs Maria Kyriazi for her invaluable help in organizing the data. A recent study by Sies and Parnham expanded on the therapeutic potential of Epselen, an organoselenium compound, as an inhibitor of SARS-CoV-2's main protease. In this study, using an unbiased, data driven bioinformatic screening of two independently extracted SARS-CoV-2 -induced host gene signatures confirms Selenium as a potential drug candidate. This pathway based approach adds transcriptomic evidence complimenting the protein-centered rationale expanded on by the authors. Given that aside from host -protein interactions, antisense transcript mRNA-mRNA interactions have been demonstrated to occur at selenocysteine related insertions in RNA viruses, transcriptomic-level evidence offer unique insight into viral lifecycles. Furthermore, the pathways identified from these two selenium associated signatures provide further insight into the perturbations of selenium metabolism introduced by SARS-CoV-2 during its lifecycle. A recent study by Sies and Parnham expanded on the therapeutic potential of Ebselen, an organoselenium compound, as an inhibitor of SARS-CoV-2's main protease. (1) The aim of this study is to provide the genomic interface of Selenium within SARS-CoV-2 infected hosts, using a data-driven approach. A Selenium compound (SELENIUM CTD 00006731) was significantly enriched in both lists and associated with two distinct gene signatures derived from each original gene set (Table 1 and 2) . Notably, Vitamin E (VITAMIN E CTD 00006994) and important co-factor for intracellular selenium was correspondingly significantly enriched (Table 1 and 2) . Raw data on all compounds are available from DOI: 10.17632/v6pymtdyck.1. Vitamin and trace metal homeostasis is a prerequisite of immune surveillance, shifting Th1/Th2 equilibrium in favor of the proinflammatory Th1 state (6) . Selenium and Vit E interdependencies become evident when considering the pleotropic effects on viral activity that are associated with their depletion (7) . Notably, selenium deprival has been shown to induce provirulent genomic modifications in latent, otherwise avirulent viruses (8), supporting its association with the viral lifecycle. Perhaps the most important and pertinent interaction between host and viruses regarding selenium efflux may lie in host -virus mRNA -mRNA tethering interactions. Studies in HIV-1 and Ebola have shown that thermodynamically stable ATIs are possible between viral and host mRNAs, and utilize a selenocysteine insertion sequence in order to produce viral selenoprotein equivalents (9) . To summarize the findings of this report, Seis and Parnham's study is supported by an unbiased, data-driven screening of two independent Selenium-associated gene signatures, derived from two separate corresponding SARS-CoV-2 -host gene lists. Aside from its imputed role in targeting SARS-CoV-2's main protease (10) and the protein -centered approached discussed by Seis and Parnham, genomic evidence further support its role in viral lifecycles, as well as their disruption. As a final note, it should be noted that selenium supplementation has been shown to result in both beneficial and detrimental effects in immunity (11), depending on its presupplementation levels as well as the actual compound used. Future studies aiming to evaluate its use in the clinical setting should take both of these parameters into account. Ivory Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections Free Radic Biol Med Proteomics of SARS-CoV-2-infected host cells reveals therapy targets Nature Master Regulator Analysis of the SARS-CoV-2/Human Interactome Enrichr: a comprehensive gene set enrichment analysis web server 2016 update Nucleic Acids Res DSigDB: drug signatures database for gene set analysis Bioinformatics Contribution of selected vitamins and trace elements to immune function Coxsackievirus B3-resistant mice become susceptible in Se/vitamin E deficiency Free Radic Biol Med Benign human enterovirus becomes virulent in selenium-deficient mice Cellular Selenoprotein mRNA Tethering via Antisense Interactions with Ebola and HIV-1 mRNAs May Impact Host Selenium SARS-CoV-2 and discovery of its inhibitors Nature